Document:

EX-10.11

 Exhibit 10.11 

Execution Version 
 TRADEMARK
SECURITY AGREEMENT 
 This TRADEMARK SECURITY AGREEMENT (this “Trademark Security Agreement”) is made this 9th day of August, 2018, by and among the Grantors listed on the signature pages hereof (collectively, jointly and severally, “Grantors” and each individually
“Grantor”), and DEERFIELD ELGX REVOLVER, LLC, a Delaware limited liability company, in its capacity as agent for each member of the Lender Group (in such capacity, together with its successors and assigns in such capacity,
“Agent”). 
 W I T N E S S E T H: 

WHEREAS, pursuant to that certain Credit Agreement dated as of August 9, 2018 (as amended, restated, supplemented, or otherwise modified
from time to time, the “Credit Agreement”) by and among ENDOLOGIX, INC., a Delaware corporation (“Endologix”), each of its direct and indirect Subsidiaries set forth on the signature pages thereto and any
additional borrower that may thereafter be added to the Credit Agreement (individually as a “Borrower”, and collectively with any entities that become party thereto as Borrower and each of their successors and permitted assigns, the
“Borrowers”), the lenders party thereto as “Lenders” (such Lenders, together with their respective successors and assigns in such capacity, each, individually, a “Lender” and, collectively, the
“Lenders”), and Agent, the Lender Group has agreed to make certain financial accommodations available to the Borrowers from time to time pursuant to the terms and conditions thereof; 

WHEREAS, the members of the Lender Group are willing to make the financial accommodations to the Borrowers as provided for in the Credit
Agreement and the other Loan Documents, but only upon the condition, among others, that Grantors shall have executed and delivered to Agent, for the benefit of the Lender Group, that certain Guaranty and Security Agreement, dated as of
August 9, 2018 (including all annexes, exhibits or schedules thereto, as from time to time amended, restated, supplemented or otherwise modified, the “Guaranty and Security Agreement”); and 

WHEREAS, pursuant to the Guaranty and Security Agreement, Grantors are required to execute and deliver to Agent, for the benefit of the Lender
Group, this Trademark Security Agreement. 
 NOW, THEREFORE, in consideration of the premises and mutual covenants herein contained and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each Grantor hereby agrees as follows: 

1. DEFINED TERMS. All initially capitalized terms used but not otherwise defined herein have the meanings given to them in the Guaranty
and Security Agreement or, if not defined therein, in the Credit Agreement, and this Trademark Security Agreement shall be subject to the rules of construction set forth in Section 1.04 of the Credit Agreement, which rules of construction are
incorporated herein by this reference, mutatis mutandis. 
 2. GRANT OF SECURITY INTEREST IN TRADEMARK COLLATERAL. Each
Grantor hereby unconditionally grants, assigns, and pledges to Agent, for the benefit of each member of the Lender Group, to secure the Secured Obligations, a continuing security interest 

 
(referred to in this Trademark Security Agreement as the “Security Interest”) in all of such Grantor’s right, title and interest in and to the following, whether now owned
or hereafter acquired or arising (collectively, the “Trademark Collateral”): 
 (a) all of its Trademarks and Trademark
Intellectual Property Licenses to which it is a party including those referred to on Schedule I; 
 (b) all goodwill of the business
connected with the use of, and symbolized by, each Trademark and each Trademark Intellectual Property License; and 
 (c) all products and
proceeds (as that term is defined in the Code) of the foregoing, including any claim by such Grantor against third parties for past, present or future (i) infringement or dilution of any Trademark or any Trademarks exclusively licensed under
any Intellectual Property License, including right to receive any damages, (ii) injury to the goodwill associated with any Trademark, or (iii) right to receive license fees, royalties, and other compensation under any Trademark
Intellectual Property License. 
 3. SECURITY FOR SECURED OBLIGATIONS. This Trademark Security Agreement and the Security Interest
created hereby secures the payment and performance of the Secured Obligations, whether now existing or arising hereafter. Without limiting the generality of the foregoing, this Trademark Security Agreement secures the payment of all amounts which
constitute part of the Secured Obligations and would be owed by Grantors, or any of them, to Agent, the other members of the Lender Group or any of them, whether or not they are unenforceable or not allowable due to the existence of an Insolvency
Proceeding involving any Grantor. 
 4. PROTECTION OF TRADEMARK SECURITY INTEREST BY GRANTORS. Each Grantor shall, at its sole cost,
reasonable expense and risk, in connection with the operation of its business, comply with the requirements set forth in Section 6 of the Guaranty and Security Agreement in respect of the Trademark Collateral. 

5. REPRESENTATIONS AND WARRANTIES. Each Grantor represents and warrants that: 

(a) Schedule I hereto is a true, correct and complete list of all Trademarks and Trademark Intellectual Property Licenses in which each Grantor
purports to have an ownership or license interest. 
 (b) Such Grantor has the legal right and authority to enter into this Trademark
Security Agreement and perform its terms. 
 (c) If such Grantor amends its name, such Grantor shall provide copies of such amendment
documentation to Agent and shall, if necessary, re-register such Grantor’s Trademarks and Trademark Intellectual Property Licenses with the appropriate Governmental Authority and shall execute and deliver
such agreements or documentation as Agent shall reasonably request in writing to maintain a perfected first priority security interest in the Trademark Collateral subject to Permitted Liens. 

  
 2 

 6. SECURITY AGREEMENT. The Security Interest in the Collateral granted pursuant to
this Trademark Security Agreement is granted in conjunction with the security interests granted to Agent, for the benefit of the Lender Group, pursuant to the Guaranty and Security Agreement. Each Grantor hereby acknowledges and affirms that the
rights and remedies of Agent with respect to the Security Interest in the Trademark Collateral made and granted hereby are more fully set forth in the Guaranty and Security Agreement, the terms and provisions of which are incorporated by reference
herein as if fully set forth herein. To the extent there is any inconsistency between this Trademark Security Agreement and the Guaranty and Security Agreement, the Guaranty and Security Agreement shall control. 

7. AUTHORIZATION TO SUPPLEMENT. If any Grantor shall obtain rights to any new trademarks, the provisions of this Trademark Security
Agreement shall automatically apply thereto. Each Grantor shall notify Agent of applications filed for the registration of any Trademarks with the United States Trademark Office in accordance with Section 5.7(g) of the Guaranty and Security
Agreement. Without limiting Grantors’ obligations under this Section, Grantors hereby authorize Agent unilaterally to modify this Trademark Security Agreement by amending Schedule I to include any such new trademark rights of each
Grantor. Notwithstanding the foregoing, no failure to so modify this Trademark Security Agreement or amend Schedule I shall in any way affect, invalidate or detract from Agent’s continuing security interest in all Collateral, whether or
not listed on Schedule I. 
 8. NO VIOLATION OF LOAN DOCUMENTS. The representations, warranties or covenants contained herein
are supplemental to those representations, warranties and covenants contained in the other Loan Documents, and shall not be deemed to modify any such representation, warranty or covenant contained in any other Loan Document. 

9. GRANTOR’S RIGHTS TO ENFORCE TRADEMARKS. Prior to Agent’s giving of notice to Grantor following the occurrence and during
the continuance of an Event of Default, such Grantor shall have the exclusive right to sue for past, present and future infringement of the Trademark Collateral, including the right to seek injunctions and/or money damages, in an effort by such
Grantor to protect the Trademark Collateral against encroachment by third parties, provided, however, that: 
 (a) Any money damages awarded
or received by such Grantor on account of such suit (or the threat of such suit) shall constitute Trademark Collateral. 
 (b) Any damages
recovered in any action pursuant to this Section, net of costs and attorneys’ fees reasonably incurred, shall be applied in accordance with the Credit Agreement and the Guaranty and Security Agreement. 

(c) Following the occurrence and during the continuance of any Event of Default, Agent, by notice to any Grantor may terminate or limit such
Grantor’s rights under this Section 9. 
 10. RIGHTS UPON DEFAULT. Upon the occurrence and during the continuance of any
Event of Default, Agent may exercise all rights and remedies as provided for in the Guaranty and Security Agreement. 

  
 3 

 11. NO LIMITATION; LOAN DOCUMENTS. This Trademark Security Agreement has been
executed and delivered by each Grantor for the purpose of recording the security interest granted to Agent with respect to the Trademark Collateral with the United States Trademark Office. The security interest granted hereby has been granted as a
supplement to, and not in limitation of, the security interest granted to Agent, for the benefit of the Lender Group, under the Guaranty and Security Agreement and the other Loan Documents. The other Loan Documents (and all rights and remedies of
Grantor, Agent, and Lenders thereunder) shall remain in full force and effect in accordance with their terms. 
 12. TERMINATION; RELEASE
OF TRADEMARK COLLATERAL. This Trademark Security Agreement and all obligations of each Grantor and Agent hereunder shall terminate on the date upon which the Obligations have been Paid in Full. Upon termination of this Trademark Security
Agreement, Agent shall, at the reasonable expense of the Grantor, take such actions required by the Credit Agreement or the Guaranty and Security Agreement or as otherwise reasonably requested by Grantor to release its security interest in the
Trademark Collateral. 
 13. BINDING EFFECT; BENEFITS. This Trademark Security Agreement shall be binding upon each Grantor and its
successors and assigns, and shall inure to the benefit of Agent, Lenders and their respective successors and assigns. 
 14.
COUNTERPARTS. This Trademark Security Agreement is a Loan Document. This Trademark Security Agreement may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered,
shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Trademark Security Agreement. Delivery of an executed counterpart of this Trademark Security Agreement by telefacsimile or other
electronic method of transmission shall be equally as effective as delivery of an original executed counterpart of this Trademark Security Agreement. Any party delivering an executed counterpart of this Trademark Security Agreement by telefacsimile
or other electronic method of transmission also shall deliver an original executed counterpart of this Trademark Security Agreement but the failure to deliver an original executed counterpart shall not affect the validity, enforceability, and
binding effect of this Trademark Security Agreement. 
 15. CHOICE OF LAW AND VENUE, JURY TRIAL WAIVER, AND JUDICIAL REFERENCE
PROVISION. THIS TRADEMARK SECURITY AGREEMENT SHALL BE SUBJECT TO THE PROVISIONS REGARDING CHOICE OF LAW AND VENUE, JURY TRIAL WAIVER, AND JUDICIAL REFERENCE SET FORTH IN SECTIONS 8.11 AND 8.12 OF THE GUARANTY AND SECURITY AGREEMENT, AND SUCH
PROVISIONS ARE INCORPORATED HEREIN BY THIS REFERENCE, MUTATIS MUTANDIS. 
 [signature page follows] 

  
 4 

 IN WITNESS WHEREOF, the parties hereto have caused this Trademark Security Agreement to be
executed and delivered as of the day and year first above written. 
  

							
	GRANTORS:	 		 	ENDOLOGIX, INC.
				
		 		 	By:	 	 /s/ Vaseem Mahboob

		 		 	Name: Vaseem Mahboob
		 		 	Title: Chief Financial Officer
			
		 		 	TRIVASCULAR, INC.
				
		 		 	By:	 	 /s/ Vaseem Mahboob

		 		 	Name: Vaseem Mahboob
		 		 	Title: Chief Financial Officer and Secretary

 [SIGNATURE PAGE TO TRADEMARK SECURITY AGREEMENT] 

			
	 IN WITNESS WHEREOF, the parties hereto have caused this Trademark Security Agreement to be executed and
delivered as of the day and year first above written.

		  	ACCEPTED AND ACKNOWLEDGED BY:
		
	AGENT:	  	DEERFIELD ELGX REVOLVER, LLC
		  	by: Deerfield Management Company, L.P. (Series C), Manager
		  	By: Flynn Management LLC, General Partner
		
		  	By: /s/ David J. Clark                                
		  	Name: David J. Clark
		  	Title: Authorized Signatory

  
 6 

 SCHEDULE I 

to 
 TRADEMARK SECURITY AGREEMENT

 Trademark Registrations/Applications 
  

									
	 Grantor
	  	 Country
	  	 Mark
	  	 Registration No.
	  	 Registration Date

	Endologix, Inc.	  	USA	  	DURAPLY	  	5433696	  	3/27/18
					
	Endologix, Inc.	  	USA	  	INTELIX	  	5059968	  	10/11/16
					
	Endologix, Inc.	  	USA	  	EVAS FORWARD	  	5306786	  	10/10/17
					
	Endologix, Inc.	  	USA	  	VELA	  	5296578	  	9/26/17
					
	Endologix, Inc.	  	USA	  	ANGIOTIP	  	5205176	  	5/16/17
					
	Endologix, Inc.	  	USA	  	ACTIVESEAL	  	5396605	  	2/6/18
					
	Endologix, Inc.	  	USA	  	INNOVATION THAT EMPOWERS	  	4841631	  	10/27/15
					
	Endologix, Inc.	  	USA	  	INNOVATION TAKING SHAPE	  	4220343	  	10/9/12
					
	Endologix, Inc.	  	USA	  	XPAND	  	4168563	  	7/3/12
					
	Endologix, Inc.	  	USA	  	AFX	  	4214460	  	9/25/12
					
	Endologix, Inc.	  	USA	  	INTUITRAK DELIVERY SYSTEM	  	3649866	  	7/7/09
					
	Endologix, Inc.	  	USA	  	INTUITRAK	  	3649757	  	7/7/09
					
	Endologix, Inc.	  	USA	  	NELLIX	  	3880178	  	11/23/10
					
	Endologix, Inc.	  	USA	  	SUREPASS	  	3593259	  	3/17/09
					
	Endologix, Inc.	  	USA	  	POWERLINK XL	  	3573999	  	2/10/09
					
	Endologix, Inc.	  	USA	  	POWERLINK	  	2456038	  	5/29/01
					
	Endologix, Inc.	  	USA	  	ENDOLOGIX	  	2257799	  	6/29/99
					
	TriVascular, Inc.	  	USA	  	OVATION ALTO	  	5195890	  	5/2/17
					
	TriVascular, Inc.	  	USA	  	CUSTOMSEAL	  	4732342	  	5/5/15
					
	TriVascular, Inc.	  	USA	  	OVATION PRIME	  	4452625	  	12/17/13
					
	TriVascular, Inc.	  	USA	  	OVATION PRIME ABDOMINAL STENT GRAFT SYSTEM	  	4449077	  	12/10/13
					
	TriVascular, Inc.	  	USA	  	TRIVASCULAR	  	4395789	  	9/3/13
					
	TriVascular, Inc.	  	USA	  	OVATION	  	4440468	  	11/26/13
					
	TriVascular, Inc.	  	USA	  	TRIVASCULAR	  	2867015	  	7/27/04EX-10.12

 Exhibit 10.12 

FIRST SUPPLEMENT TO PATENT SECURITY AGREEMENT 

This FIRST SUPPLEMENT TO PATENT SECURITY AGREEMENT (this “Supplement”) made as of August 9, 2018, by Endologix, Inc., a
Delaware corporation (“Endologix” or “Borrower”), Nellix, Inc., a Delaware corporation (“Nellix”), TriVascular, Inc., a Delaware corporation (“TriVascular”; TriVascular, Endologix
and Nellix are each individually a “Grantor” and collectively “Grantors”), in favor of Deerfield Private Design Fund IV, L.P., in its capacity as Agent for the Secured Parties (each as defined in the Facility
Agreement referenced below) (in such capacity, “Grantee”): 
 W I T N E S S E T H 

WHEREAS, Borrower, the other Loan Parties (including Nellix and TriVascular) from time to time party thereto, the financial institutions from
time to time party thereto as Lenders and Grantee have entered into that certain Amended and Restated Facility Agreement dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Facility
Agreement”), pursuant to which Grantee and the Lenders have agreed, subject to the terms and conditions thereof, to make certain loans to, and other credit accommodations in favor of, Borrower (collectively, the “Loans”).

 WHEREAS, pursuant to the terms of that certain Amended and Restated Guaranty and Security Agreement dated as of the date hereof, by and
among Grantee, Grantors and the other Loan Parties from time to time party thereto (as the same may be amended, restated, supplemented or otherwise modified from time to time, the “Guaranty and Security Agreement”), Grantors have
granted to Grantee, for its benefit and the benefit of the other Secured Parties, a security interest and Lien upon substantially all assets (including the Collateral) of Grantors, including all right, title and interest of Grantors in, to
and under all now owned and hereafter acquired (a) letters patent of the United States or any political subdivision thereof of each Grantor, all reissues and extensions thereof and all goodwill associated therewith, (b) applications for
letters patent of the United States and all divisions of each Grantor, continuations and continuations-in-part thereof and (c) rights to, and the rights to obtain
any reissues, reexaminations, continuations, continuations-in-part, divisionals, renewals and extensions of all the foregoing (all of the foregoing in clauses (a), (b)
and (c), collectively, together with all “Patents” as defined in the Guaranty and Security Agreement, “Patents”), together with the goodwill of the business symbolized by Grantors’ Patents, and all income, royalties,
damages and payments with respect to the foregoing, to secure the payment of all Secured Obligations, in each case other than Excluded Property. 

WHEREAS, Grantors and Grantee are parties to a certain Patent Security Agreement dated April 3, 2017 (as the same heretofore may have
been and hereafter may be amended, restated, supplemented or otherwise modified from time to time, the “Patent Security Agreement”). 

NOW, THEREFORE, in consideration of the premises set forth herein and for other good and valuable consideration, receipt and sufficiency of
which are hereby acknowledged, Grantors agree to supplement the Patent Security Agreement as follows: 
 1. Incorporation of Facility
Agreement, Guaranty and Security Agreement and Patent Security Agreement. The representations and warranties contained in the Facility 

 
Agreement, the Guaranty and Security Agreement and the Patent Security Agreement to the extent applicable to Grantors are hereby incorporated herein in their entirety by this reference thereto.
The provisions of Sections 1.2 and 6.4 of the Facility Agreement are incorporated herein by reference thereto mutatis mutandis. Unless otherwise noted herein, all capitalized terms used herein but not otherwise defined herein shall have
the respective meanings ascribed to such terms in the Guaranty and Security Agreement, or if not defined therein, in the Facility Agreement. In the event of a conflict between a provision of the Guaranty and Security Agreement and a provision of
this Supplement (or the Patent Security Agreement as amended and/or supplemented by this Supplement), the provision of the Guaranty and Security Agreement shall control. 

2. Grant and Reaffirmation of Grant of Security Interests. To secure the payment of the Secured Obligations, Grantors grant to Grantee,
for its benefit and the benefit of the other Secured Parties, and hereby reaffirm their prior grant pursuant to the Guaranty and Security Agreement and the Patent Security Agreement of, a continuing Lien on and security interest in Grantors’
entire right, title and interest in and to the following (all of the following items or types of property being herein collectively referred to as the “Patent Collateral”), whether now owned or existing or hereafter created,
acquired or arising: 
 (a) each Patent listed on Schedule A annexed hereto and all other Patents, together with any
reissues, reexaminations, continuations, continuations-in-part, divisionals, renewals and extensions thereof, all of the goodwill of the business connected with the use
of, and symbolized by, each such Patent, and all proceeds and products with respect to the foregoing; and 
 (b) all income,
royalties, damages and payments at any time due or payable or asserted under and with respect to the foregoing, including without limitation, damages payable with respect to any claim by Grantors against third parties for past, present or future
(i) infringement or dilution of each such Patent, or (ii) injury to the goodwill associated with each such Patent, and all proceeds and products with respect to the foregoing. 

Notwithstanding the foregoing, no Patent Collateral shall include any Excluded Property. 

3. Incorporation of the Patent Security Agreement. The terms and provisions of the Patent Security Agreement are hereby incorporated by
reference and this Supplement shall be considered an amendment and supplement to and part of the Patent Security Agreement, all of the provisions of which Patent Security Agreement are and remain in full force and effect. Any reference after the
date hereof in any Loan Document to the Patent Security Agreement shall be a reference to the Patent Security Agreement as amended and supplemented by this Supplement. 

4. Reaffirmation of Obligations. Each Grantor hereby reaffirms its obligations (including, without limitation, the Obligations
(including any Non-Callable Make Whole Amount, any CoC Fee and any Exit Payment)) under the Patent Security Agreement, the Guaranty and Security Agreement and all other Loan Documents. Each Grantor hereby
further ratifies and reaffirms the validity and enforceability of all of the Liens and security interests heretofore granted, pursuant to and in connection with the Patent Security Agreement, the Security Agreement or any other Loan Document, to
Grantee (for the benefit of the Secured Parties), as collateral security for the obligations (including, without limitation, the Obligations 

 
(including any Non-Callable Make Whole Amount, any CoC Fee and any Exit Payment)) under the Loan Documents in accordance with their respective terms, and
acknowledges that all of such Liens and security interests, and all Collateral (including, without limitation, the Patent Collateral (as defined in the Patent Security Agreement)) heretofore pledged as security for such obligations (including,
without limitation, the Obligations (including any Non-Callable Make Whole Amount, any CoC Fee and any Exit Payment)), continue to be and remain collateral for such obligations (including, without limitation,
the Obligations(including any Non-Callable Make Whole Amount, any CoC Fee and any Exit Payment)) from and after the date hereof. 

5. Ratification. Each Grantor hereby restates, ratifies and reaffirms each and every term and condition set forth in the Patent Security
Agreement effective as of the date hereof and as amended hereby. 
 6. Governing Law. This Supplement is governed by and construed and
enforced in accordance with the laws of the State of New York applicable to contracts made and to be performed in such State. 
 7.
Counterparts. This Supplement may be executed in several counterparts, and by each Party on separate counterparts, each of which and any photocopies, facsimile copies and other electronic methods of transmission thereof shall be deemed an
original, but all of which together shall constitute one and the same agreement. 
 [Signature Page Follows] 

 IN WITNESS WHEREOF, each Grantor has duly executed this Supplement as of the date first
written above. 
  

			
	ENDOLOGIX, INC.
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer

 First Supplement to Patent Security Agreement 

 IN WITNESS WHEREOF, each Grantor has duly executed this Supplement as of the date first
written above. 
  

			
	NELLIX, INC.
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary

 First Supplement to Patent Security Agreement 

 IN WITNESS WHEREOF, each Grantor has duly executed this Supplement as of the date first
written above. 
  

			
	TRIVASCULAR, INC.
		
	By:	 	 /s/ Vaseem Mahboob

	Name:	 	Vaseem Mahboob
	Title:	 	Chief Financial Officer and Secretary

 First Supplement to Patent Security Agreement 

			
	 Agreed and Accepted
 As of the Date
First Written Above:

	
	 DEERFIELD PRIVATE DESIGN FUND IV, L.P., as Agent and Grantee

as Agent
  

By: Deerfield Mgmt IV, L.P., General Partner
  

By: J.E. Flynn Capital IV, LLC, General Partner

		
	By:	 	 /s/ David J. Clark

	Name:	 	David J. Clark
	Title:	 	Authorized Signatory

 First Supplement to Patent Security Agreement 

 SCHEDULE A 

 

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	Patent No.	  	Registration
Date	  	 Owner/

Applicant

	Bifurcated vascular graft deployment device	  	09505038	  	2/16/00	  	6210422	  	4/3/01	  	Endologix, Inc.
						
	Method of deploying bifurcated vascular graft	  	09086247	  	5/28/98	  	6156063	  	12/5/00	  	Endologix, Inc.
						
	Bifurcated vascular graft deployment device	  	08802478	  	2/20/97	  	6090128	  	7/18/00	  	Endologix, Inc.
						
	Inflatable implant	  	12628623	  	12/1/09	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Ptfe layers and methods of manufacturing	  	12250946	  	10/14/08	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Ptfe layers and methods of manufacturing	  	12250915	  	10/14/08	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Hybrid modular endovascular graft	  	11097718	  	4/1/05	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Non-degradable low swelling, water soluble radiopaque hydrogel polymer	  	11097467	  	4/1/05	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Delivery system and method for bifurcated graft	  	11205793	  	8/15/05	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Methods, compositions and devices for embolizing body lumens	  	11031311	  	1/7/05	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Endoluminal prosthesis endoleak management	  	10691849	  	10/22/03	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Layered endovascular graft	  	10803153	  	3/17/04	  	N/A	  	N/A	  	Trivascular, Inc.

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	 Patent No.
	  	 Registration
Date
	  	 Owner/

Applicant

	Delivery system and method for bifurcated graft	  	10686863	  	10/16/03	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Inflatable intraluminal graft	  	10289137	  	11/5/02	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Endovascular graft	  	10289136	  	11/5/02	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Advanced endovascular graft	  	10091641	  	3/5/02	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Delivery system and method for bifurcated graft	  	10122474	  	4/11/02	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Layered endovascular graft	  	09970576	  	10/3/01	  	N/A	  	N/A	  	Trivascular, Inc.
						
	Dual inflatable arterial prosthesis	  	15540246	  	6/27/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Catheter system and methods of using same	  	15632064	  	6/23/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Catheter system and methods of using same	  	15639028	  	6/30/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Apparatus and method of placement of a graft or graft system	  	15610242	  	5/31/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Stent graft delivery system	  	15676869	  	8/14/17	  	N/A	  	N/A	  	Nellix, Inc.
						
	Endovascular graft	  	15686214	  	8/25/17	  	N/A	  	N/A	  	TriVascular, Inc.
						
	Advanced endovascular graft	  	15686218	  	8/25/17	  	N/A	  	N/A	  	TriVascular, Inc.
						
	Endovascular graft for aneurysms involving major branch vessels	  	15638559	  	6/30/17	  	N/A	  	N/A	  	TriVascular, Inc.
						
	Systems and methods for guidewire crossover for bifurcated	  	15491074	  	4/19/17	  	N/A	  	N/A	  	TriVascular, Inc.

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	 Patent
No.
	  	 Registration
Date
	  	 Owner/

Applicant

	Low profile stent graft and delivery system	  	15263469	  	9/13/16	  	N/A	  	N/A	  	TriVascular, Inc.
						
	Endoluminal prosthesis systems and methods	  	15737223	  	12/15/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Endovascular graft systems and methods for deployment in main and branch arteries	  	65/529663	  	7/7/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Stent grants and methods of enhancing flexibility of stent grafts by thermal pleating	  	65/532737	  	7/14/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Endoluminal device and polymer	  	62/575827	  	10/23/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Systems and Methods with Stents and Filling Structure	  	62/382207	  	8/31/16	  	N/A	  	N/A	  	Endologix, Inc.
						
	STENTS, GRAFTS, DELIVERY SYSTEMS, AND METHODS	  	62/481560	  	4/4/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	ENDOVASCULAR SYSTEMS, DEVICES, AND METHODS ALLOWING FOR BRANCH DEVICE PLACEMENT IN POCKET OF MAIN GRAFT	  	62/489213	  	4/24/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	ENDOVASCULAR GRAFT SYSTEMS AND METHODS FOR DEPLOYMENT IN MAIN AND BRANCH ARTERIES	  	62/529669	  	7/7/17	  	N/A	  	N/A	  	Endologix, Inc.

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	 Patent
No.
	  	 Registration
Date
	  	 Owner/

Applicant

						
	STENT GRAFTS AND METHODS OF ENHANCING FLEXIBILITY OF STENT GRAFTS BY THERMAL PLEATING	  	62/532737	  	7/14/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	STENT GRAFT	  	15/911629	  	3/5/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	INTERNAL ILIAC PRESERVATION DEVICES AND METHODS	  	15/965649	  	4/__/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	MODULATION OF INFLAMMATORY RESPONSE FOLLOWING ENDOVASCULAR TREATMENT	  	62/661569	  	4/23/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	ADVANCED KINK RESISTANT STENT GRAFT	  	16/005269	  	6/11/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	LOW PROFILE STENT GRAFT AND DELIVERY SYSTEM	  	15/985572	  	5/21/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	SYSTEMS AND METHODS WITH STENT AND FILLING STRUCTURE	  	15/774511	  	8/30/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	LONGITUDINALLY EXTENDABLE STENT GRAFT SYSTEMS AND METHODS	  	15/774548	  	1/23/18	  	N/A	  	N/A	  	Endologix, Inc.

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	 Patent No.
	  	 Registration
Date
	  	 Owner/

Applicant

						
	GRAFT SYSTEMS HAVING FILLING STRUCTURES SUPPORTED BY SCAFFOLDS AND METHODS FOR THEIR USE	  	16/035497	  	7/13/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	PRE-FIXATION DEVICE FOR NELLIX AND OTHER EVAS DEVICES	  	62/678956	  	5/31/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	SYSTEMS AND METHODS WITH FENESTRATED GRAFT AND FILLING STRUCTURE	  	16/066595	  		  	N/A	  	N/A	  	Endologix, Inc.
						
	MODULATION OF INFLAMMATORY RESPONSE FOLLOWING ENDOVASCULAR TREATMENT	  	62/661569	  	4/23/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	ENDOLUMINAL DEVICE AND POLYMER	  	62/575827	  	10/23/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Implantable vascular graft	  	12/860280	  	8/20/10	  	20100318174	  		  	Endologix, Inc.
						
	Endoluminal vascular prosthesis	  	11/623679	  	1/16/07	  	2007012412	  		  	Endologix, Inc.
						
	Delivery catheter for endovascular device	  	13/835491	  	3/15/13	  	9498363	  	11/22/16	  	Trivascular, Inc.
						
	Stent-graft with improved flexibility	  	15568834	  	10/24/17	  	N/A	  	N/A	  	TriVascular, Inc.
						
	System and methods of Endovasular Aneurysm Treatment	  	14682414	  	8/21/17	  	N/A	  	N/A	  	Nellix, Inc.

											
	 Description/Title
	  	Application
No.	  	Application
Date	  	 Patent No.
	  	 Registration
Date
	  	 Owner/

Applicant

	Stent graft systems with restraints in circumferential channels and methods thereof	  	62/678961	  	5/31/18	  	N/A	  	N/A	  	Endologix, Inc.
						
	Percutaneous method and device to treat dissections	  	15/429090	  	2/9/17	  	N/A	  	N/A	  	Endologix, Inc.
						
	Endovascular delivery system with an improved radiopague marker scheme	  	16/049560	  	7/30/18	  	N/A	  	N/A	  	Nellix, Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]